Source:http://linkedlifedata.com/resource/pubmed/id/10547588
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-3-9
|
pubmed:abstractText |
Primary effusion lymphoma (PEL) is a novel lymphoproliferative disorder associated with human herpesvirus 8 (HHV-8) infection. Most PELs develop in HIV-seropositive individuals and are nearly always positive for Epstein-Barr virus (EBV), a finding which obscures the role of HHV-8 in lymphomagenesis. However, rare EBV-negative PEL cases occurring in HIV-seronegative patients have been reported, suggesting that HHV-8 may be pathogenetic by itself. To investigate whether HHV-8 may contribute to PEL development in the absence of EBV, the expression of seven potentially oncogenic HHV-8 open reading frames (ORFs) (ORF72/viral cyclin D, ORF16/viral bcl-2, ORF74/viral G-protein coupled receptor, ORFK2/viral IL-6, ORFK13/viral FLICE inhibitory protein, ORFK9/viral interferon regulatory factor, and ORFK1, equivalent to the gene encoding herpesvirus saimiri transforming protein) was assessed by reverse transcriptase-polymerase chain reaction (RT-PCR) in an EBV-negative PEL presenting in an HIV-negative patient. RNA transcripts were demonstrated for the seven HHV-8 genes, and this was confirmed by hybridization to specific oligonucleotide probes. The expression of potentially oncogenic HHV-8 genes in this HIV-, EBV-negative PEL case suggests that HHV-8 may induce malignant transformation of B-lymphocytes through different molecular pathways in the absence of EBV infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-3417
|
pubmed:author |
pubmed-author:BoschFF,
pubmed-author:CampySS,
pubmed-author:CobbSS,
pubmed-author:EsteveJJ,
pubmed-author:HernándezLL,
pubmed-author:HernándezSS,
pubmed-author:JaffeE SES,
pubmed-author:López-GuillermoAA,
pubmed-author:MontserratEE,
pubmed-author:PalacínAA,
pubmed-author:PinyolMM,
pubmed-author:RaffeldMM
|
pubmed:copyrightInfo |
Copyright 1999 John Wiley & Sons, Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
189
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
288-93
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10547588-Gene Expression,
pubmed-meshheading:10547588-HIV Seronegativity,
pubmed-meshheading:10547588-Herpesvirus 4, Human,
pubmed-meshheading:10547588-Herpesvirus 8, Human,
pubmed-meshheading:10547588-Humans,
pubmed-meshheading:10547588-Lymphoma, B-Cell,
pubmed-meshheading:10547588-Male,
pubmed-meshheading:10547588-Middle Aged
|
pubmed:year |
1999
|
pubmed:articleTitle |
Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient.
|
pubmed:affiliation |
Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|